{"title":"Kidney Diseases","description":null,"products":[{"product_id":"kerendia-10mg-tablets-28s","title":"Kerendia 10mg Tablets 28'S","description":"\u003cspan class=\"markedContent\" id=\"page1137R_mcid254\" style='padding: 0px; margin: 0px; color: transparent; position: absolute; white-space: pre; cursor: text; transform-origin: 0% 0%; top: 0px; height: 0px; font-family: \"Times New Roman\"; font-size: medium;'\u003eIihyaf tgfwsbfytiqw trf68qI\r\n\r\n\u003cp class=\"MsoNormal\"\u003e\u003cspan style='font-size:12.0pt;line-height:107%;font-family:\n\"Times New Roman\",serif'\u003eerendia is a non-steroidal mineralocorticoid receptor\r\nantagonist (MRA) indicated to reduce the risk of sustained eGFR decline, end\r\nstage kidney disease, cardiovascular death, non-fatal myocardial infarction,\r\nand hospitalization for heart failure in adult patients with chronic kidney\r\ndisease (CKD) associated with type 2 diabetes (T2D)\u003co:p\u003e\u003c\/o:p\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp class=\"MsoNormal\"\u003e\u003cspan style='font-size:12.0pt;line-height:107%;font-family:\n\"Times New Roman\",serif'\u003eerendia is a non-steroidal mineralocorticoid receptor\r\nantagonist (MRA) indicated to reduce the risk of sustained eGFR decline, end\r\nstage kidney disease, cardiovascular death, non-fatal myocardial infarction,\r\nand hospitalization for heart failure in adult patients with chronic kidney\r\ndisease (CKD) associated with type 2 diabetes (T2D)\u003co:p\u003e\u003c\/o:p\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\r\n\u003cspan role=\"presentation\" dir=\"ltr\" style=\"padding: 0px; margin: 0px; position: absolute; cursor: text; transform-origin: 0% 0%; left: 60px; top: 204.636px; font-size: 13.4px; font-family: serif; transform: scaleX(0.995533);\"\u003eerendia is a non-steroidal mineralocorticoid receptor antagonist (MRA)\u003c\/span\u003e\u003c\/span\u003e\u003cspan class=\"markedContent\" id=\"undefined\" style='padding: 0px; margin: 0px; color: transparent; position: absolute; white-space: pre; cursor: text; transform-origin: 0% 0%; top: 0px; height: 0px; font-family: \"Times New Roman\"; font-size: medium;'\u003e\u003c\/span\u003e\u003cspan class=\"markedContent\" id=\"page1137R_mcid255\" style='padding: 0px; margin: 0px; color: transparent; position: absolute; white-space: pre; cursor: text; transform-origin: 0% 0%; top: 0px; height: 0px; font-family: \"Times New Roman\"; font-size: medium;'\u003e\u003cbr role=\"presentation\" style=\"padding: 0px; margin: 0px; position: absolute; cursor: text; transform-origin: 0% 0%;\"\u003e\u003cspan role=\"presentation\" dir=\"ltr\" style=\"padding: 0px; margin: 0px; position: absolute; cursor: text; transform-origin: 0% 0%; left: 60px; top: 222.236px; font-size: 13.4px; font-family: serif; transform: scaleX(0.995106);\"\u003eindicated to reduce the risk of sustained eGFR decline, end stage kidney\u003c\/span\u003e\u003c\/span\u003e\u003cspan class=\"markedContent\" id=\"undefined\" style='padding: 0px; margin: 0px; color: transparent; position: absolute; white-space: pre; cursor: text; transform-origin: 0% 0%; top: 0px; height: 0px; font-family: \"Times New Roman\"; font-size: medium;'\u003e\u003c\/span\u003e\u003cspan class=\"markedContent\" id=\"page1137R_mcid256\" style='padding: 0px; margin: 0px; color: transparent; position: absolute; white-space: pre; cursor: text; transform-origin: 0% 0%; top: 0px; height: 0px; font-family: \"Times New Roman\"; font-size: medium;'\u003e\u003cbr role=\"presentation\" style=\"padding: 0px; margin: 0px; position: absolute; cursor: text; transform-origin: 0% 0%;\"\u003e\u003cspan role=\"presentation\" dir=\"ltr\" style=\"padding: 0px; margin: 0px; position: absolute; cursor: text; transform-origin: 0% 0%; left: 60px; top: 239.836px; font-size: 13.4px; font-family: serif; transform: scaleX(0.995091);\"\u003edisease, cardiovascular death, non-fatal myocardial infarction, and\u003c\/span\u003e\u003c\/span\u003e\u003cspan class=\"markedContent\" id=\"undefined\" style='padding: 0px; margin: 0px; color: transparent; position: absolute; white-space: pre; cursor: text; transform-origin: 0% 0%; top: 0px; height: 0px; font-family: \"Times New Roman\"; font-size: medium;'\u003e\u003c\/span\u003e\u003cspan class=\"markedContent\" id=\"page1137R_mcid257\" style='padding: 0px; margin: 0px; color: transparent; position: absolute; white-space: pre; cursor: text; transform-origin: 0% 0%; top: 0px; height: 0px; font-family: \"Times New Roman\"; font-size: medium;'\u003e\u003cbr role=\"presentation\" style=\"padding: 0px; margin: 0px; position: absolute; cursor: text; transform-origin: 0% 0%;\"\u003e\u003cspan role=\"presentation\" dir=\"ltr\" style=\"padding: 0px; margin: 0px; position: absolute; cursor: text; transform-origin: 0% 0%; left: 60px; top: 257.436px; font-size: 13.4px; font-family: serif; transform: scaleX(0.995419);\"\u003ehospitalization for heart failure in adult patients with chronic kidney disease\u003c\/span\u003e\u003c\/span\u003e\u003cspan class=\"markedContent\" id=\"undefined\" style='padding: 0px; margin: 0px; color: transparent; position: absolute; white-space: pre; cursor: text; transform-origin: 0% 0%; top: 0px; height: 0px; font-family: \"Times New Roman\"; font-size: medium;'\u003e\u003c\/span\u003e\u003cspan class=\"markedContent\" id=\"page1137R_mcid258\" style='padding: 0px; margin: 0px; color: transparent; position: absolute; white-space: pre; cursor: text; transform-origin: 0% 0%; top: 0px; height: 0px; font-family: \"Times New Roman\"; font-size: medium;'\u003e\u003cbr role=\"presentation\" style=\"padding: 0px; margin: 0px; position: absolute; cursor: text; transform-origin: 0% 0%;\"\u003e\u003cspan dir=\"ltr\" aria-owns=\"pdfjs_internal_id_1107R\" style=\"padding: 0px; margin: 0px; position: absolute; cursor: text; transform-origin: 0% 0%; left: 60px; top: 275.236px; font-size: 13.4px; font-family: serif; transform: scaleX(0.996599);\"\u003e(CKD) associated with type 2 diabetes (T2D)\u003c\/span\u003e\u003c\/span\u003e","brand":"KERENDIA","offers":[{"title":"Default Title","offer_id":44942339244205,"sku":"62936","price":446.0,"currency_code":"QAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0680\/6434\/6285\/files\/kerendia-10mg-tablets-28s-1.jpg?v=1783022132"},{"product_id":"kerendia-20mg-tablets-28s","title":"Kerendia 20mg Tablets 28'S","description":"Kerendia is used for the treatment of adults with chronic kidney disease (stage 3 and 4 with\nabnormal presence of the protein albumin in the urine) associated with type 2 diabetes.  ","brand":"KERENDIA","offers":[{"title":"Default Title","offer_id":44942352941229,"sku":"62941","price":446.0,"currency_code":"QAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0680\/6434\/6285\/files\/kerendia-20mg-tablets-28s-1.jpg?v=1783022133"},{"product_id":"uralyt-u-granules-280gm","title":"Uralyt U Granules 280gm","description":"To dissolve uric acid stones in the urinary tract.\nPrevention of further stone formation.","brand":"URALYT","offers":[{"title":"Default Title","offer_id":45905468784813,"sku":"22069","price":54.0,"currency_code":"QAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0680\/6434\/6285\/files\/uralyt-u-granules-280gm-1.jpg?v=1783042974"}],"url":"https:\/\/www.wellcareonline.com\/collections\/kidney-diseases.oembed","provider":"Wellcare Pharmacy","version":"1.0","type":"link"}